GSK Head Discusses Company Interest In NTDs The Associated Press features a Q&A with GlaxoSmithKline (GSK) CEO Andrew Witty, who "is pushing to sell more products in fast-growing 'emerging markets' such as Brazil, Russia, India and China" while simultaneously "increasing efforts to bring medicines for tropical diseases to the poorest countries, at minimum profit...
More...
More...